Citadel Advisors »

Forte Biosciences shares owned by Citadel Advisors

Quarter-by-quarter ownership of Forte Biosciences (FBRX) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Forte Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Forte Biosciences held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Forte Biosciences by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $235k 16k 15.00

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Spdr Gold Tr Gold Shs Call Option (GLD)
Ishares Tr Russell 2000 Etf (IWM)
Amazon Call Option (AMZN)
Strategy Cl A New Call Option (MSTR)
Alphabet Cap Stk Cl A Call Option (GOOGL)
UnitedHealth Call Option (UNH)
Palantir Technologies Cl A Call Option (PLTR)
Netflix Call Option (NFLX)

View all positions for Citadel Advisors

Top funds holding Forte Biosciences

Fred Alger Management
Federated Investors
Henderson Group
OrbiMed Advisors
Tybourne Capital Management
Vanguard Group
Cable Car Capital
Sphera Funds Management
Adage Capital Partners GP
Woodline Partners
Ikarian Capital
AWM Investment Company
FMR
Millennium Management
Geode Capital Management

View all funds holding Forte Biosciences